BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 21, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Sep. 19, 2024

View Archived Issues
3D illustration of transparent human torso with close up of spinal cord

FDA clears Avicenna algorithm to detect cervical spine fractures

Avicenna.ai SAS received U.S. FDA clearance for its Cina-Cspine algorithm, which uses machine learning technology to detect and triage cervical spine fractures from computed tomography images. The tool automatically flags imaging findings that are compatible with acute cervical spine fractures, which can cause serious neurological damage or paralysis. Read More
Gears with regulatory words

MDMA urges CMS to craft separate outpatient payments for RDN devices

The U.S. CMS believes it has a quandary on its hands with regard to transitional pass-through payment for renal denervation devices, but the Medical Device Manufacturers Association urged the agency to provide separate payment mechanisms for these devices as seen in the inpatient final rule. Read More
Tinted Euro symbol

Non-dilutive funding comes with challenges panel says

As med-tech startups look to raise capital without diluting the valuation of their company, many may look to sell distribution rights in certain geographies to interested companies. Read More
Melanoma cells stained with an H & E stain and magnified to 320x.

AI Medi Scan develops at-home melanoma detection app

Australia is the skin cancer capital of the world, but with a shortage of dermatologists, patients often wait too long to get skin checks that could end up costing them their lives. Read More
Juleen Zierath on stage at EASD 2024

Studies on exercise and health win EASD prize

How do exercise and insulin collaborate in metabolism? The European Association for the Study of Diabetes (EASD) and the Novo Nordisk Foundation recognized the work of Juleen Zierath in this topic with the Diabetes Prize for Excellence at their recent annual meeting. Read More

Appointments and advancements for September 19, 2024

New hires and promotions in the med-tech industry, including: Biocentriq, Ecential Robotics, Elekta, Halix, Renovos. Read More

Financings for September 19, 2024

Med-tech firms raising money in public or private financings, including: Aerflow Health, Aerflow Ventures, Canopie Health. Read More

In the clinic for September 19, 2024

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aces Diagnostics, Dermasensor, Focus on Lyme. Read More

Other news to note for September 19, 2024

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Achari Ventures, Arrayus, Astellas, Avenda, Biognosys, Bracco, Cairn, Dasa, DUB Enterprises, Edap, Eko, Imac, Jupiter Endovascular, Konica Minolta Healthcare, Leap Distributors, Leap Surgical, MGI Tech, Newvue, Thermo Fisher, Vaso. Read More

Regulatory actions for September 19, 2024

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avicenna, GE Healthcare, Sonio. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 20, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Microscopic view of the ebola virus

    WHO declares Ebola outbreak a public health emergency of international concern

    BioWorld
    The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • Nxera Pharma prepares and tests new GPR17 antagonists

    BioWorld Science
    Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing